GreenLight Announces Completion of Merger with Fall Line Endurance Fund
24. Juli 2023 09:49 ET
|
GreenLight Biosciences
LEXINGTON, Mass., July 24, 2023 (GLOBE NEWSWIRE) -- GreenLight Biosciences Holdings, PBC (NASDAQ: GRNA) (“GreenLight” or the “Company”) today announced the closing of its previously announced...
GreenLight Biosciences Announces Expiration of Tender Offer Period for Outstanding Shares
20. Juli 2023 08:06 ET
|
GreenLight Biosciences
LEXINGTON, Mass., July 20, 2023 (GLOBE NEWSWIRE) -- GreenLight Biosciences Holdings, PBC (NASDAQ: GRNA) (“GreenLight” or the “Company”) today announced that it is initiating the final steps in...
GreenLight Biosciences Announces First Quarter 2023 Financial Results and Highlights Recent Company Progress
11. Mai 2023 07:00 ET
|
GreenLight Biosciences
BOSTON, May 11, 2023 (GLOBE NEWSWIRE) -- GreenLight Biosciences, PBC (Nasdaq: GRNA), a biotechnology company dedicated to making RNA products affordable and accessible for human health and...
GreenLight Biosciences Announces Fourth Quarter and Full Year 2022 Financial Results
28. März 2023 17:05 ET
|
GreenLight Biosciences
Two agriculture solutions now under regulatory review, pending EPA approval: Calantha™, a solution to protect potatoes, and a separate solution to protect honeybees from Varroa miteUpdated clinical...
GreenLight Biosciences Announces Third Quarter 2022 Financial Results and Highlights Recent Company Progress
09. November 2022 17:07 ET
|
GreenLight Biosciences
Working toward clinical trial initiation for COVID vaccine candidate in 2023Shingles vaccine candidate selection planned for 2023 in partnership with Serum Institute of IndiaCalantha™, Colorado potato...
GreenLight Biosciences to Participate in Upcoming Investor Conferences in November
07. November 2022 11:25 ET
|
GreenLight Biosciences
BOSTON, Nov. 07, 2022 (GLOBE NEWSWIRE) -- GreenLight Biosciences (Nasdaq: GRNA), a public benefit corporation striving to deliver on the potential of RNA to address some of the world’s toughest...
GreenLight Biosciences announces realignment to focus on near-term value drivers
12. Oktober 2022 06:54 ET
|
GreenLight Biosciences
BOSTON, Oct. 12, 2022 (GLOBE NEWSWIRE) -- GreenLight Biosciences (Nasdaq: GRNA), a public benefit corporation striving to bring effective and safe solutions to make food clean and affordable for...
GreenLight Biosciences and Queensland University of Technology partner to tackle destructive fall armyworm using RNA
05. Oktober 2022 09:36 ET
|
GreenLight Biosciences
GreenLight Biosciences and Queensland University of Technology (QUT) partner to create a solution for fall armywormFall armyworm is one of the most destructive insect pests on the planet, causing more...
GreenLight Biosciences announces $109 million financing
12. August 2022 07:21 ET
|
GreenLight Biosciences
BOSTON, Aug. 12, 2022 (GLOBE NEWSWIRE) -- GreenLight Biosciences (Nasdaq: GRNA), a public benefit corporation striving to bring effective and safe solutions to make food clean and affordable for...
GreenLight Biosciences and Samsung Biologics complete first commercial-scale engineering run for mRNA Covid-19 vaccine
01. August 2022 09:00 ET
|
GreenLight Biosciences
GreenLight’s messenger RNA production process is transferable to large-scale equipment and CMO facilitiesTechnology transfer and scale-up from lab bench to Samsung’s commercial facility was completed...